PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs. read more
Stuart Peltz PTC Therapeutics CEO Rating
Stuart Peltz PTC Therapeutics CEO Rating
PTC Therapeutics' CEO, Stuart Peltz, has 5 employee ratings and a score of 76/100, placing them in the Top 30% of similar size companies on Comparably with 51-200 Employees and Top 20% of other companies in New York.
Where This Score Ranks PTC Therapeutics' CEO Rating
- TOP30%
In the Top 30% of 2035 Similar Sized Companies on Comparably
- TOP20%
In the Top 20% of 707 Nearby Companies in New York
- 1st
1st place versus 4 competitors rated on Comparably
80
Jul
75
Jul
77
Mar
83
Aug
B76 / 100
Jan
PTC Therapeutics CEO Stuart Peltz Bio
Stuart Peltz serves as the CEO / President of PTC Therapeutics.
Not Enough Ratings To Show Who Ranks CEO Rating the Highest
Anonymously rate my experience at PTC TherapeuticsNot Enough Ratings To Show Who Ranks CEO Rating the Lowest
Anonymously rate my experience at PTC TherapeuticsPTC Therapeutics CEO Stuart Peltz At a Glance
The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at PTC Therapeutics.
Based on 5 ratings, Stuart Peltz ranks right above Biogen's CEO, Michel Vounatsos.
Overall, the CEO score has remained stable over the last 90 days.
PTC Therapeutics CEO Stuart Peltz Rating Trendline
- PTC Therapeutics76
- Other Companies in New York
- Similar Size on Comparably
PTC Therapeutics' CEO Rating Rank Against Similar Sized Companies on Comparably
TOP
30%
PTC Therapeutics ranks in the Top 30% of other companies on Comparably with 51-200 Employees for CEO Rating Score.
PTC Therapeutics' CEO Rating Rank Against Other Companies Nearby
TOP
20%
PTC Therapeutics ranks in the Top 20% of other companies in New York for CEO Rating Score.
Anonymously Ask PTC Therapeutics Any Question
Are You an Employee at PTC Therapeutics?
Anonymously Rate Your Experience & Make Work BetterSee other culture dimensions at PTC Therapeutics
×